Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

44.31
Delayed Data
As of 3:59pm ET
 -0.01 / -0.02%
Today’s Change
36.58
Today|||52-Week Range
47.82
+13.35%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.

Performance

1 month+2.51% 3 years+0.36%
3 months+7.03% 5 years+12.10%
1 year-1.63% Since inception+12.22%
Data through 07/22/2017

Quote Details

Previous close$44.32
Open day’s range44.10 – 44.50
Net asset value (NAV)44.33 (07/21/2017)
Daily volume36,360
Average volume (3 months)88,611
Data as of 3:59pm ET, 07/24/2017

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+12.10%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.621.14
Net assets$452.0M$3.0B
Average market cap$8.8B$30.8B
Average P/E28.424.5
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MNK Mallinckrodt Plc4.84%
PRGO Perrigo Company PLC4.60%
AGN Allergan4.55%
BMY Bristol-Myers Squibb4.51%
PFE Pfizer4.46%
LLY Eli Lilly and Co4.42%
HZNP Horizon Pharma PLC4.39%
AKRX Akorn Inc4.39%
JNJ Johnson & Johnson4.38%
JAZZ Jazz Pharmaceuticals PLC4.37%